Search

Your search keyword '"RABBIT diseases"' showing total 149 results

Search Constraints

Start Over You searched for: Descriptor "RABBIT diseases" Remove constraint Descriptor: "RABBIT diseases" Publication Year Range This year Remove constraint Publication Year Range: This year
149 results on '"RABBIT diseases"'

Search Results

1. Clinical Pathology Evaluation in Pet Rabbits Vaccinated Against Rabbit Hemorrhagic Disease Virus 2 (RHDV2).

2. Nutritional Value of Oregano-Based Products and Its Effect on Rabbit Performance and Health.

3. Effects of Vitis vinifera Leaves on the Oxidative Status of New Zealand Rabbit Liver Infected with Eimeria stiedae.

4. Surveillance of Wildlife Viruses: Insights from South Australia's Monitoring of Rabbit Haemorrhagic Disease Virus (RHDV GI.1 and GI.2).

5. New Insights into Rabbit Viral Diseases.

6. HEV in Blood Donors in Switzerland: The Route to Safe Blood Products.

7. Antibody response of endangered riparian brush rabbits to vaccination against rabbit hemorrhagic disease virus 2.

8. Development of a peptide-generated antibody to rabbit hemorrhagic disease virus 2 VP60 and its immunohistochemical application in natural cases.

9. Clinicopathologic findings and causes of mortality in 100 pet rabbits from the Canary Islands, Spain, 2011–2022.

10. Diseases of domestic rabbits by purpose; a retrospective study of 2,583 cases received at 4 diagnostic laboratories in California, USA, 2013–2022.

11. Rabbit hemorrhagic disease virus 2, 2010–2023: a review of global detections and affected species.

12. Causes of morbidity and mortality in wild cottontail rabbits in the eastern United States, 2013–2022.

13. Effects of Dietary Inclusion of Saccharina latissima and Ulva lactuca on Growth Performance and Gut Health in Growing Rabbits.

14. Rabbit Hemorrhagic Disease Virus in Mexico in 2020–2021: Risk Areas and Climatic Distribution.

15. Practical Suggestions for Assessing Rabbit Haemorrhagic Disease Virus 2 Risk to Endangered Native Lagomorphs in North America and Southern Africa.

16. Intragenic MFSD8 duplication and histopathological findings in a rabbit with neuronal ceroid lipofuscinosis.

17. Effects of a High Trans Fatty Acid Diet on Kidney-, Liver-, and Heart-Associated Diseases in a Rabbit Model.

18. Immunohistochemical Detection of Indoleamine 2,3-Dioxygenase in Spontaneous Mammary Carcinomas of 96 Pet Rabbits.

19. IDENTIFICATION AND CHARACTERIZATION OF THE CURRENTLY CIRCULATING RABBIT HEMORRHAGIC DISEASE VIRUS ISOLATES.

20. Lagoviruses in European brown hares, first serologic evidence for RHDVa.

22. First Report of Single Nucleotide Polymorphisms (SNPs) of the Leporine Shadow of Prion Protein Gene (SPRN) and Absence of Nonsynonymous SNPs in the Open Reading Frame (ORF) in Rabbits.

23. Study on Changes in Gut Microbiota and Microbiability in Rabbits at Different Developmental Stages.

24. Assessment of Postbiotic, Mundticin-like Substance EM 41/3 Application in Broiler Rabbits.

25. Comment on Shah et al. Genetic Characteristics and Phylogeographic Dynamics of Lagoviruses, 1988–2021. Viruses 2023, 15 , 815 †.

26. Reply to Abrantes et al. Recombination-Based Perspectives on Lagovirus Classification, Phylogenetic Patterns, and Evolutionary Dynamics. Comment on "Shah et al. Genetic Characteristics and Phylogeographic Dynamics of Lagoviruses, 1988–2021. Viruses 2023, 15 , 815"

27. Do land managers apply best-practice integrated pest management: a case study of the European rabbit.

28. Characterisation of Pasteurella multocida Strains from Different Lesions in Rabbits.

29. The low-density lipoprotein receptor and apolipoprotein E associated with CCHFV particles mediate CCHFV entry into cells.

30. Characterisation of Lagovirus europaeus GI–RHDVs (Rabbit Haemorrhagic Disease Viruses) in Terms of Their Pathogenicity and Immunogenicity.

31. Exploring rabbit as a nonrodent species for general toxicology studies.

32. Functional characterization of variants found in Japanese patients with hereditary hemorrhagic telangiectasia.

33. Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin‐like effect and increased haemorrhagic risk.

34. 河南地区兔源克雷伯氏菌耐药性及耐药基因的分析.

35. A case of pulmonary linguatulosis in a rabbit.

36. Type I Cystatin Derived from Cysticercus pisiformis —Stefins, Suppresses LPS-Mediated Inflammatory Response in RAW264.7 Cells.

37. Rabbit intakes and predictors of their length of stay in animal shelters in British Columbia, Canada.

38. Computed Tomographic Findings of Dental Disease and Secondary Diseases of the Head Area in Client-Owned Domestic Rabbits (Oryctolagus cuniculus): 90 Cases.

39. Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries.

40. Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits.

41. First Detection and Circulation of RHDV2 in New Zealand.

42. Neglected Spleen Transcriptional Profile Reveals Inflammatory Disorder Conferred by Rabbit Hemorrhagic Disease Virus 2 Infection.

43. Effects of diet on the bacterial and eukaryotic microbiota across the gastrointestinal tract of healthy rabbits (Oryctolagus cuniculus).

44. Non-contrast T1ρ dispersion versus Gd-EOB-DTPA-enhanced T1mapping for the risk stratification of non-alcoholic fatty liver disease in rabbit models.

45. PREVALENCE AND RISK FACTORS OF EIMERIA SPP. AND GIARDIA SPP. IN RABBITS OF LOCAL ALGERIAN POPULATION.

46. Effect of Single-dose Pimobendan on Echocardiographic Parameters in Healthy New Zealand White Rabbits.

47. Epidemiological characterization and risk assessment of rabbit haemorrhagic disease virus 2 (RHDV2/b/GI.2) in the world.

48. MicroRNAs participate in the regulation of apoptosis and oxidative stress-related gene expression in rabbits infected with Lagovirus europaeus GI.1 and GI.2 genotypes.

49. Functional characterization of Francisella tularensis subspecies holarctica genotypes during tick cell and macrophage infections using a proteogenomic approach.

50. Immunogenicity and safety in rabbits of a Clostridioides difficile vaccine combining novel toxoids and a novel adjuvant.

Catalog

Books, media, physical & digital resources